
### [MONDO:0018634](http://purl.obolibrary.org/obo/MONDO_0018634)
**Label:** hereditary amyloidosis

**Subclasses:** [MONDO:0005620](http://purl.obolibrary.org/obo/MONDO_0005620) (cerebral amyloid angiopathy), [MONDO:0011583](http://purl.obolibrary.org/obo/MONDO_0011583) (cerebral amyloid angiopathy, App-related), [MONDO:0007100](http://purl.obolibrary.org/obo/MONDO_0007100) (familial amyloid neuropathy), [MONDO:0007099](http://purl.obolibrary.org/obo/MONDO_0007099) (familial visceral amyloidosis), [MONDO:0017132](http://purl.obolibrary.org/obo/MONDO_0017132) (hereditary ATTR amyloidosis), [MONDO:0018591](http://purl.obolibrary.org/obo/MONDO_0018591) (ITM2B amyloidosis), 

**Corr. equiv. classes:** [Orphanet:85450](http://www.orpha.net/ORDO/Orphanet_85450), [OMIM:605714](http://purl.obolibrary.org/obo/OMIM_605714), [Orphanet:271861](http://www.orpha.net/ORDO/Orphanet_271861), [OMIM:105200](http://purl.obolibrary.org/obo/OMIM_105200), [Orphanet:85458](http://www.orpha.net/ORDO/Orphanet_85458), [Orphanet:85447](http://www.orpha.net/ORDO/Orphanet_85447), [Orphanet:439254](http://www.orpha.net/ORDO/Orphanet_439254), [OMIM:105210](http://purl.obolibrary.org/obo/OMIM_105210), 

**Class expressions from DL-Learner:**

- [HP:0011034](http://purl.obolibrary.org/obo/HP_0011034) (Amyloidosis) and [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) 62.50%
- [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) and [HP:0011034](http://purl.obolibrary.org/obo/HP_0011034) (Amyloidosis) 62.50%
- [HP:0011034](http://purl.obolibrary.org/obo/HP_0011034) (Amyloidosis) and [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) and [HP:0100659](http://purl.obolibrary.org/obo/HP_0100659) (Abnormality of the cerebral vasculature) 62.50%
- [HP:0011034](http://purl.obolibrary.org/obo/HP_0011034) (Amyloidosis) and [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) and [HP:0100543](http://purl.obolibrary.org/obo/HP_0100543) (Cognitive impairment) 62.50%
- [HP:0011034](http://purl.obolibrary.org/obo/HP_0011034) (Amyloidosis) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) and [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) 62.50%
- [HP:0011034](http://purl.obolibrary.org/obo/HP_0011034) (Amyloidosis) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) and [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) 62.50%
- [HP:0011034](http://purl.obolibrary.org/obo/HP_0011034) (Amyloidosis) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) and [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) 62.50%
- [HP:0011034](http://purl.obolibrary.org/obo/HP_0011034) (Amyloidosis) and [HP:0011446](http://purl.obolibrary.org/obo/HP_0011446) (Abnormality of higher mental function) and [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) 62.50%
- [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) and [HP:0011034](http://purl.obolibrary.org/obo/HP_0011034) (Amyloidosis) and [HP:0100659](http://purl.obolibrary.org/obo/HP_0100659) (Abnormality of the cerebral vasculature) 62.50%
- [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) and [HP:0011034](http://purl.obolibrary.org/obo/HP_0011034) (Amyloidosis) and [HP:0100543](http://purl.obolibrary.org/obo/HP_0100543) (Cognitive impairment) 62.50%
- [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) and [HP:0011034](http://purl.obolibrary.org/obo/HP_0011034) (Amyloidosis) and [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) 62.50%
- [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) and [HP:0011034](http://purl.obolibrary.org/obo/HP_0011034) (Amyloidosis) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 62.50%
- [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) and [HP:0011034](http://purl.obolibrary.org/obo/HP_0011034) (Amyloidosis) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 62.50%
- [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) and [HP:0011034](http://purl.obolibrary.org/obo/HP_0011034) (Amyloidosis) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) 62.50%
- [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) and [HP:0011034](http://purl.obolibrary.org/obo/HP_0011034) (Amyloidosis) and [HP:0011446](http://purl.obolibrary.org/obo/HP_0011446) (Abnormality of higher mental function) 62.50%


